BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9539636)

  • 1. Improving the gastrointestinal safety of NSAIDs: the development of misoprostol--from hypothesis to clinical practice.
    Silverstein FE
    Dig Dis Sci; 1998 Mar; 43(3):447-58. PubMed ID: 9539636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who needs prophylaxis of nonsteroidal anti-inflammatory drug-induced ulcers and what is optimal prophylaxis?
    Goldstein JL
    Eur J Gastroenterol Hepatol; 2000 Jun; 12 Suppl 1():S11-5. PubMed ID: 10929893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
    Graham DY
    Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol: a prostaglandin for peptic ulcer.
    DiPalma JR
    Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underutilization of preventive strategies in patients receiving NSAIDs.
    Sturkenboom MC; Burke TA; Dieleman JP; Tangelder MJ; Lee F; Goldstein JL
    Rheumatology (Oxford); 2003 Nov; 42 Suppl 3():iii23-31. PubMed ID: 14585915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
    Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and gastroduodenal safety of a fixed combination of diclofenac and misoprostol in the treatment of arthritis.
    McKenna F
    Br J Rheumatol; 1995 Apr; 34 Suppl 1():11-8. PubMed ID: 7780674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention and therapy of NSAID-induced ulcers: fact versus myth].
    Fried M; Bertschinger P
    Schweiz Med Wochenschr; 1996 Sep; 126(37):1569-72. PubMed ID: 8927961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diclofenac/misoprostol. A review of its pharmacology and therapeutic efficacy in painful inflammatory conditions.
    Davis R; Yarker YE; Goa KL
    Drugs Aging; 1995 Nov; 7(5):372-93. PubMed ID: 8573992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diclofenac/misoprostol. Pharmacoeconomic implications of therapy.
    Plosker GL; Lamb HM
    Pharmacoeconomics; 1999 Jul; 16(1):85-98. PubMed ID: 10539124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of nonsteroidal anti-inflammatory drug-induced gastroduodenal ulcers: role of mucosal protective and gastric antisecretory drugs.
    Dajani EZ; Agrawal NM
    Dig Dis; 1995 Jan; 13 Suppl 1():48-61. PubMed ID: 7697902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newer, safer nonsteroidal anti-inflammatory drugs. Rational NSAID selection for arthritis.
    Bensen W; Zizzo A
    Can Fam Physician; 1998 Jan; 44():101-2, 105-7. PubMed ID: 9481468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NSAID-induced gastroduodenal damage: is prevention needed? A review and metaanalysis.
    Stalnikowicz R; Rachmilewitz D
    J Clin Gastroenterol; 1993 Oct; 17(3):238-43. PubMed ID: 7901267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoprotection with misoprostol: use in the treatment and prevention of ulcers.
    Ballinger A
    Dig Dis; 1994; 12(1):37-45. PubMed ID: 8200123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of nonsteroidal anti-inflammatory drug-induced gastroduodenal disease by acid suppression.
    Lad R; Armstrong D
    Can J Gastroenterol; 1999 Mar; 13(2):135-42. PubMed ID: 10203432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cost effectiveness of diclofenac plus misoprostol compared with diclofenac monotherapy in patients with rheumatoid arthritis.
    Al MJ; Michel BC; Rutten FF
    Pharmacoeconomics; 1996 Aug; 10(2):141-51. PubMed ID: 10163417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of upper gastrointestinal problems in patients taking NSAIDs.
    Prichard P
    Aust Fam Physician; 1991 Dec; 20(12):1739-41. PubMed ID: 1687198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of NSAID-induced ulcers by the coadministration of misoprostol: implications in clinical practice.
    Numo R
    Scand J Rheumatol Suppl; 1992; 92():25-9. PubMed ID: 1574685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of prostaglandin derivatives and mucoprotective drugs in treatment and prevention for NSAIDs-induced ulcer].
    Fujikawa Y; Watanabe T; Tominaga K; Fujiwara Y; Sato H; Arakawa T
    Nihon Rinsho; 2011 Jun; 69(6):1039-43. PubMed ID: 21688624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.